Picture of Bio Solution Co logo

086820 Bio Solution Co Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual income statement for Bio Solution Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue8,8827,74411,80210,10212,462
Cost of Revenue
Gross Profit5,9024,3007,6085,9278,120
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses10,75011,07413,37415,39017,492
Operating Profit-1,868-3,330-1,572-5,289-5,031
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-698-1,800-1,685-8,087-1,249
Provision for Income Taxes
Net Income After Taxes-698-1,800-1,685-8,087-1,249
Net Income Before Extraordinary Items
Net Income-698-1,800-1,685-8,087-1,249
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-698-1,800-1,685-8,087-1,249
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-89-226-212-1,009-156
Dividends per Share